Matthew Perry

Founder at

Nordic Biotech Advisors ApS

52 year

57 connections

Finance

Health Technology

Commercial Services

Profile

Matthew D.
Perry is the founder of Nordic Biotech Advisors ApS.
Mr. Perry is currently President at Biotechnology Value Fund LP.
Mr. Perry is Managing Partner at Coastlands Capital LP starting in 2025.
Formerly, Mr. Perry was Independent Non-Executive Director at CTI BioPharma Corp.
from 2016 to 2023.
Mr. Perry was President & Director at BVF, Inc. Mr. Perry was Director at Ziarco Pharma Ltd. Mr. Perry was Independent Director at XOMA Royalty Corp.
from 2017 to 2026.
Mr. Perry was President & Portfolio Manager at BVF Partners LP.
Mr. Perry was Account Executive at Feinstein Kean Partners, Inc. from 1994 to 1996.
Mr. Perry was Account Executive at Feinstein Kean Healthcare from 1994 to 1996.
Mr. Perry completed undergraduate studies at The College of William & Mary in 1994.

Matthew Perry active positions

Companies	Position	Start
Nordic Biotech Advisors ApS Nordic Biotech Advisors ApS Investment ManagersFinance NB Capital is an active manager which provides financing for pre-seed, seed, later, and growth-stage capital requirements, and invests in both public and private companies. The firm invests in young and established companies operating in the health technology sector, and industries such as biotechnology and pharmaceuticals. NB Capital invests in companies located in Denmark, Northern Europe, and North America, and looks to take minority stake positions in its investments, as well as a seat on the board.	Founder	-
Biotechnology Value Fund LP Biotechnology Value Fund LP Investment Trusts/Mutual FundsMiscellaneous Functions as a hedge fund	President	-

All active positions of Matthew Perry

Former positions of Matthew Perry

Companies	Position	End
XOMA ROYALTY CORPORATION	Director/Board Member	14/07/2026
CTI BIOPHARMA CORP.	Director/Board Member	23/06/2023
Feinstein Kean Partners, Inc. Feinstein Kean Partners, Inc. Miscellaneous Commercial ServicesCommercial Services Public relations firm	Corporate Officer/Principal	01/12/1996
Feinstein Kean Healthcare Feinstein Kean Healthcare Miscellaneous Commercial ServicesCommercial Services Provides strategic communications consulting services	Corporate Officer/Principal	01/01/1996
Ziarco Pharma Ltd. Ziarco Pharma Ltd. BiotechnologyHealth Technology Provides therapeutics targeting inflammatory and allergic diseases	Director/Board Member	-

See the detail of Matthew Perry's experience

Training of Matthew Perry

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Matthew Perry's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Biotechnology Value Fund LP Biotechnology Value Fund LP Investment Trusts/Mutual FundsMiscellaneous Functions as a hedge fund	Miscellaneous
CTI BioPharma Corp. CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers	Health Technology
XOMA Royalty Corp. XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics	Health Technology
BVF, Inc. BVF, Inc. Investment Banks/BrokersFinance Manages hedge funds and engages in investment business	Finance
BVF Partners LP BVF Partners LP Investment ManagersFinance BVF generally pursues value-oriented investment strategies, investing primarily in the marketable securities issued by biotechnology companies. The focus of the BVF strategy is on fundamental, bottom-up analysis of individual issuers based on the theory that market mispricing exist because market prices do not incorporate all knowable economic and other relevant data.	Finance
Feinstein Kean Partners, Inc. Feinstein Kean Partners, Inc. Miscellaneous Commercial ServicesCommercial Services Public relations firm	Commercial Services
The College of William & Mary The College of William & Mary Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Nordic Biotech Advisors ApS Nordic Biotech Advisors ApS Investment ManagersFinance NB Capital is an active manager which provides financing for pre-seed, seed, later, and growth-stage capital requirements, and invests in both public and private companies. The firm invests in young and established companies operating in the health technology sector, and industries such as biotechnology and pharmaceuticals. NB Capital invests in companies located in Denmark, Northern Europe, and North America, and looks to take minority stake positions in its investments, as well as a seat on the board.	Finance
Feinstein Kean Healthcare Feinstein Kean Healthcare Miscellaneous Commercial ServicesCommercial Services Provides strategic communications consulting services	Commercial Services
Ziarco Pharma Ltd. Ziarco Pharma Ltd. BiotechnologyHealth Technology Provides therapeutics targeting inflammatory and allergic diseases	Health Technology